Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

ClinicalTrials.gov public records Last synced May 21, 2026, 11:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–2 of 2 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Condition: Healthcare-associated Pneumonia (HCAP) Clear all

Completed Phase 3 Interventional Results available

Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens

NCT02714595

View directory record Official record

Conditions: Healthcare-associated Pneumonia (HCAP), Bloodstream Infections (BSI), Hospital Acquired Pneumonia (HAP), Complicated Urinary Tract Infection (cUTI), Sepsis, Ventilator Associated Pneumonia (VAP)
Interventions: Cefiderocol, Best Available Therapy; Drug
Lead sponsor: Shionogi; Industry
Eligibility: 18 Years and older

Enrollment: 152 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 6
States / cities: Hartford, Connecticut • Newark, Delaware • Chicago, Illinois + 3 more

Source: ClinicalTrials.gov public record

Updated Jan 11, 2021 · Synced May 21, 2026, 11:39 PM EDT

Completed Phase 3 Interventional Results available

Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens

NCT03032380

View directory record Official record

Conditions: Healthcare-associated Pneumonia (HCAP), Hospital Acquired Pneumonia (HAP), Ventilator Associated Pneumonia (VAP)
Interventions: Cefiderocol, Meropenem, Linezolid; Drug
Lead sponsor: Shionogi; Industry
Eligibility: 18 Years and older

Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 15
States / cities: New Haven, Connecticut • DeLand, Florida • Chicago, Illinois + 12 more

Source: ClinicalTrials.gov public record

Updated Nov 12, 2020 · Synced May 21, 2026, 11:39 PM EDT